Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Biozentrum University of Basel|Spitalstrasse 41|Basel

  1. Events
  2. Venues
  3. Biozentrum University of Basel|Spitalstrasse 41|Basel
Events at this venue
Today

Peptide Therapeutics Forum 2025

The Peptide Therapeutics Forum 2025, taking place in Basel on June 5th and 6th, provides a crucial and innovative platform for the exchange of knowledge [...]

Contractors

Timesheet Portal

Clients
Legal
Contact Us

Copyright © 2025 | Hlx Life Sciences

Site by theLEAP

Go to Top